Sec. 307. Research and coordination of activities concerning the long-term health effects of SARS–CoV–2 infection
519 words·~2 min read·
/bill/118/s/2333/is/section-307·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of Health and Human Services (referred to in this section as the Secretary ) shall, as appropriate— coordinate activities among relevant Federal departments and agencies with respect to addressing the long-term health effects of SARS–CoV–2 infection, which may include conditions that arise as a result of such infection; continue to conduct or support basic, clinical, epidemiological, behavioral, and translational research and public health surveillance related to the pathogenesis, prevention, diagnosis, and treatment of the long-term health effects of SARS–CoV–2 infection and re-infection, which may include conditions and any effects on development, cognition, and neural structure and function that arise as a result of such infection; and consistent with the findings of studies and research under paragraph (1), in consultation with health and public health professional associations, scientific and medical researchers, and other relevant experts, develop and inform recommendations, guidance, and educational materials on the long-term effects of SARS–CoV–2 infection, which may include conditions that arise as a result of such infection, and provide such recommendations, guidance, and educational materials to health care providers and the general public.
In conducting or supporting research under this section, the Secretary shall consider the diversity of research participants or cohorts to ensure inclusion of a broad range of participants, as applicable and appropriate. The Secretary may— acting through the Director of the Agency for Healthcare Research and Quality, conduct or support research related to— the improvement of health care delivery for individuals experiencing long-term health effects of SARS–CoV–2, which may include conditions that arise as a result of such infection; the identification of any trends associated with differences in diagnosis and treatment of the long-term health effects of SARS–CoV–2 infection and related conditions; and the development or identification of tools and strategies to help health care entities and providers care for such populations, which may include addressing any differences identified pursuant to subparagraph (B); publicly disseminate the results of such research; and establish a primary care technical assistance initiative to convene primary care providers and organizations, which may include support for continuing training and education for such providers, as applicable and appropriate, in order to collect and disseminate best practices related to the care of individuals with long-term health effects of SARS–CoV–2 infection, which may include conditions that arise as a result of such infection.
Not later than 1 year after the date of enactment of this Act, and annually thereafter for the next 4 years, the Secretary shall prepare and submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives regarding an overview of the research conducted or supported under this section and any relevant findings. Such reports may include information about how the research and relevant findings under this section relate to other research efforts supported by other public or private entities.
In making information or reports publicly available under this section, the Secretary shall take into consideration the delivery of such information in a manner that takes into account the range of communication needs of the intended recipients, including at-risk individuals.